Anti‐EGFR‐Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept
T Dragovich, C Campen - Journal of oncology, 2009 - Wiley Online Library
Cancers of the esophagus and stomach present a major health burden worldwide. In the
past 30 years we have witnessed some interesting shifts in terms of epidemiology of …
past 30 years we have witnessed some interesting shifts in terms of epidemiology of …
[PDF][PDF] Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept
T Dragovich, C Campen - growth - researchgate.net
The estimated incidence of esophageal and gastric cancer in the United States is 16470 and
21500 in the United States, respectively, in 2008 [1]. Worldwide figures indicate nearly …
21500 in the United States, respectively, in 2008 [1]. Worldwide figures indicate nearly …
Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept.
T Dragovich, C Campen - Journal of Oncology, 2009 - europepmc.org
Cancers of the esophagus and stomach present a major health burden worldwide. In the
past 30 years we have witnessed some interesting shifts in terms of epidemiology of …
past 30 years we have witnessed some interesting shifts in terms of epidemiology of …
[PDF][PDF] Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept
T Dragovich, C Campen - growth - Citeseer
The estimated incidence of esophageal and gastric cancer in the United States is 16470 and
21500 in the United States, respectively, in 2008 [1]. Worldwide figures indicate nearly …
21500 in the United States, respectively, in 2008 [1]. Worldwide figures indicate nearly …
[PDF][PDF] Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept
T Dragovich, C Campen - growth - scienceopen.com
The estimated incidence of esophageal and gastric cancer in the United States is 16470 and
21500 in the United States, respectively, in 2008 [1]. Worldwide figures indicate nearly …
21500 in the United States, respectively, in 2008 [1]. Worldwide figures indicate nearly …
Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept
T Dragovich, C Campen - Journal of oncology, 2009 - pubmed.ncbi.nlm.nih.gov
Cancers of the esophagus and stomach present a major health burden worldwide. In the
past 30 years we have witnessed some interesting shifts in terms of epidemiology of …
past 30 years we have witnessed some interesting shifts in terms of epidemiology of …
[PDF][PDF] Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept
T Dragovich, C Campen - growth - pdfs.semanticscholar.org
The estimated incidence of esophageal and gastric cancer in the United States is 16470 and
21500 in the United States, respectively, in 2008 [1]. Worldwide figures indicate nearly …
21500 in the United States, respectively, in 2008 [1]. Worldwide figures indicate nearly …
[HTML][HTML] Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept
T Dragovich, C Campen - Journal of Oncology, 2009 - ncbi.nlm.nih.gov
Cancers of the esophagus and stomach present a major health burden worldwide. In the
past 30 years we have witnessed some interesting shifts in terms of epidemiology of …
past 30 years we have witnessed some interesting shifts in terms of epidemiology of …
Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept.
T Dragovich, C Campen - Journal of Oncology, 2009 - search.ebscohost.com
Cancers of the esophagus and stomach present a major health burden worldwide. In the
past 30 years we have witnessed some interesting shifts in terms of epidemiology of …
past 30 years we have witnessed some interesting shifts in terms of epidemiology of …
[引用][C] Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept
T Dragovich, C Campen - Journal of Oncology, 2009 - airitilibrary.com